Document is current
Any future updates will be listed below
-
Authors
Shi, Honglue https://orcid.org/0000-0003-3847-1652
Rangadurai, Atul
Abou Assi, Hala
Roy, Rohit
Case, David A.
Herschlag, Daniel
Yesselman, Joseph D.
Al-Hashimi, Hashim M. https://orcid.org/0000-0003-0681-1747
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R01GM132899)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U54 AI150470)
- License Information
-
More Information
Article History
Received: 4 July 2020
Accepted: 7 October 2020
First Online: 2 November 2020
Competing interests
: H.M.A. is an advisor to and holds an ownership interest in Nymirum, an RNA-based drug discovery company. The remaining authors declare no competing interests.
